DAVENPORT & Co LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DAVENPORT & Co LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$146,926
-29.3%
208,701
-9.9%
0.00%
-50.0%
Q1 2023$207,813
-25.2%
231,701
-1.7%
0.00%0.0%
Q4 2022$278,000
-85.4%
235,701
-6.7%
0.00%
-88.2%
Q3 2022$1,902,000
+34.2%
252,601
+12.3%
0.02%
+41.7%
Q2 2022$1,417,000
-25.7%
224,901
-2.0%
0.01%
-7.7%
Q1 2022$1,906,000
+55.6%
229,601
-2.8%
0.01%
+62.5%
Q4 2021$1,225,000
-51.4%
236,101
-37.5%
0.01%
-55.6%
Q3 2021$2,522,000
+7.3%
377,500
+36.9%
0.02%0.0%
Q2 2021$2,350,000
-6.0%
275,800
-2.4%
0.02%
-21.7%
Q1 2021$2,500,000
-27.2%
282,500
+1.1%
0.02%
-32.4%
Q4 2020$3,435,000
+82.6%
279,500
+20.9%
0.03%
+61.9%
Q3 2020$1,881,000
-19.5%
231,100
-5.1%
0.02%
-25.0%
Q2 2020$2,338,000
+38.3%
243,550
-2.0%
0.03%
+16.7%
Q1 2020$1,690,000
-55.4%
248,550
-2.3%
0.02%
-41.5%
Q4 2019$3,789,000254,3000.04%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$6,144,0004.00%
P.A.W. CAPITAL CORP 380,000$3,363,0002.96%
INTERWEST VENTURE MANAGEMENT CO 764,918$6,770,0001.78%
Telemetry Investments, L.L.C. 150,477$1,332,0001.51%
683 Capital Management, LLC 2,683,600$23,750,0001.26%
KNOTT DAVID M 276,535$2,447,0001.05%
Trellus Management Company, LLC 226,000$2,000,0001.04%
TOWERVIEW LLC 140,000$1,239,0000.77%
Vivo Capital, LLC 1,791,257$15,853,0000.56%
CAXTON CORP 94,083$833,0000.54%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders